Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Background
Condylomata acuminata, commonly known as genital warts, is a sexually transmitted infection (STI) caused by certain strains of the human papillomavirus (HPV). HPV is a group of viruses that can infect the genital and anal areas, as well as the mouth and throat. Â
The primary cause of genital warts is infection with HPV, particularly strains 6 and 11. These strains are considered low-risk and are not associated with an increased risk of cancer.Â
Genital warts often appear as small, flesh-colored bumps or growths in the genital or anal area. They can be raised or flat and may occur singly or in clusters. Â
Â
Epidemiology
HPV is one of the most common sexually transmitted infections globally. The prevalence of HPV infection varies across populations, with higher rates seen in sexually active individuals.Â
Both men and women can develop genital warts, and the prevalence is generally similar in both genders. Genital warts are primarily transmitted through sexual contact, including vaginal, anal, and oral sex.Â
Risk factors for acquiring genital warts include having multiple sexual partners, engaging in unprotected sex, and a history of other sexually transmitted infections.Â
Â
Anatomy
Pathophysiology
Genital warts are primarily transmitted through direct skin-to-skin contact during sexual activity. HPV enters the body through microabrasions or breaks in the skin or mucous membranes of the genital, anal, or oral areas.Â
The virus enters the host cell and establishes a productive infection, leading to the replication of viral DNA. The virus completes its life cycle in the differentiated layers of the epithelium, leading to the production of viral particles.Â
HPV has evolved mechanisms to evade the immune system, allowing it to establish persistent infections. The virus can interfere with host immune responses, making it challenging for the body to clear the infection.Â
Â
Etiology
Genital warts are primarily caused by infection with HPV, a group of DNA viruses. HPV is highly prevalent, and there are over 100 known types, with some affecting the genital and anal areas.Â
These types are considered low risk because they are not associated with an increased risk of cancer, unlike high-risk HPV types that are linked to cancers such as cervical cancer.Â
HPV is primarily transmitted through direct skin-to-skin contact, usually during sexual activity. Transmission can occur through vaginal, anal, or oral sex, and the virus can be passed even when there are no visible warts.Â
The virus infects basal epithelial cells, which are found in the outer layer of the skin and mucous membranes.Â
Â
Genetics
Prognostic Factors
The immune system plays a crucial role in controlling and clearing HPV infections, including those causing genital warts.Â
Individuals with compromised immune systems, such as those with HIV or on immunosuppressive medications, may experience more persistent or recurrent infections.Â
Â
Clinical History
Age Group:Â Â
Genital warts are frequently diagnosed in individuals who are sexually active during their late teens and early twenties.Â
Genital warts are primarily transmitted through sexual contact, including vaginal, anal, and oral sex.Â
Individuals become more sexually active during their late teens and early twenties, leading to an increased risk of exposure to HPV.Â
Â
Physical Examination
Â
Age group
Associated comorbidity
In pregnant women, genital warts can pose certain risks, especially if the warts are present in the genital or perianal area.Â
In rare cases, the presence of large warts may necessitate interventions during childbirth to prevent obstruction of the birth canal.Â
While Condylomata acuminata itself is not directly linked to HIV transmission, the presence of genital warts may increase the risk of HIV acquisition or transmission in individuals who are also at risk for HIV.Â
Â
Associated activity
Acuity of presentation
For individuals who do develop visible warts, the onset can be relatively rapid after exposure to the human papillomavirus (HPV).Â
Warts may appear within weeks or months of acquiring the infection. The acuity may also depend on the location and size of the warts. Warts in more visible or sensitive areas may prompt individuals to seek medical attention sooner.Â
The individual’s immune response plays a significant role in the acuity of genital warts. Those with a robust immune response may clear the infection more effectively or experience a milder presentation.Â
Â
Differential Diagnoses
Â
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Â
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
use-of-non-pharmacological-approach-for-condylomata-acumina
Use of an immune response modifiers
Â
Use of topical antimitotic agents
Podofilox: It is a topical antimitotic agent that interferes with cell division, leading to the death of HPV-infected cells.Â
Use of Interferon
Interferon: Interferon is a protein with antiviral properties that may be injected directly into the warts (intralesional injection) to stimulate the immune system’s response.Â
use-of-intervention-with-a-procedure-in-treating-condylomata-acumina
Â
use-of-phases-in-managing-condylomata-acumina
Medication
For the topical treatment of condyloma acuminata on the external genitals in adults, either a 0.15% cream or a 0.5% solution is recommended
The standard dosage involves applying the treatment twice daily for a duration of three days
If necessary, the regimen can be repeated at weekly intervals for a total treatment period of four weeks
The maximum daily application for the 0.5% solution should not exceed 0.5 mL, covering an area of wart tissue up to 10 square centimeters
This approach provides specific guidelines for the targeted treatment of condyloma acuminata, ensuring proper application and duration for effective management
Dose Adjustments
Limited data is available
Apply 0.5% solution or 0.15% cream twice daily for 3 days or once a week for 4 weeks, if needed
Administer dose of 1 million units injected into each lesion 3 times/week every day for 3 week
Future Trends
Condylomata acuminata, commonly known as genital warts, is a sexually transmitted infection (STI) caused by certain strains of the human papillomavirus (HPV). HPV is a group of viruses that can infect the genital and anal areas, as well as the mouth and throat. Â
The primary cause of genital warts is infection with HPV, particularly strains 6 and 11. These strains are considered low-risk and are not associated with an increased risk of cancer.Â
Genital warts often appear as small, flesh-colored bumps or growths in the genital or anal area. They can be raised or flat and may occur singly or in clusters. Â
Â
HPV is one of the most common sexually transmitted infections globally. The prevalence of HPV infection varies across populations, with higher rates seen in sexually active individuals.Â
Both men and women can develop genital warts, and the prevalence is generally similar in both genders. Genital warts are primarily transmitted through sexual contact, including vaginal, anal, and oral sex.Â
Risk factors for acquiring genital warts include having multiple sexual partners, engaging in unprotected sex, and a history of other sexually transmitted infections.Â
Â
Genital warts are primarily transmitted through direct skin-to-skin contact during sexual activity. HPV enters the body through microabrasions or breaks in the skin or mucous membranes of the genital, anal, or oral areas.Â
The virus enters the host cell and establishes a productive infection, leading to the replication of viral DNA. The virus completes its life cycle in the differentiated layers of the epithelium, leading to the production of viral particles.Â
HPV has evolved mechanisms to evade the immune system, allowing it to establish persistent infections. The virus can interfere with host immune responses, making it challenging for the body to clear the infection.Â
Â
Genital warts are primarily caused by infection with HPV, a group of DNA viruses. HPV is highly prevalent, and there are over 100 known types, with some affecting the genital and anal areas.Â
These types are considered low risk because they are not associated with an increased risk of cancer, unlike high-risk HPV types that are linked to cancers such as cervical cancer.Â
HPV is primarily transmitted through direct skin-to-skin contact, usually during sexual activity. Transmission can occur through vaginal, anal, or oral sex, and the virus can be passed even when there are no visible warts.Â
The virus infects basal epithelial cells, which are found in the outer layer of the skin and mucous membranes.Â
Â
The immune system plays a crucial role in controlling and clearing HPV infections, including those causing genital warts.Â
Individuals with compromised immune systems, such as those with HIV or on immunosuppressive medications, may experience more persistent or recurrent infections.Â
Â
Age Group:Â Â
Genital warts are frequently diagnosed in individuals who are sexually active during their late teens and early twenties.Â
Genital warts are primarily transmitted through sexual contact, including vaginal, anal, and oral sex.Â
Individuals become more sexually active during their late teens and early twenties, leading to an increased risk of exposure to HPV.Â
Â
Â
In pregnant women, genital warts can pose certain risks, especially if the warts are present in the genital or perianal area.Â
In rare cases, the presence of large warts may necessitate interventions during childbirth to prevent obstruction of the birth canal.Â
While Condylomata acuminata itself is not directly linked to HIV transmission, the presence of genital warts may increase the risk of HIV acquisition or transmission in individuals who are also at risk for HIV.Â
Â
For individuals who do develop visible warts, the onset can be relatively rapid after exposure to the human papillomavirus (HPV).Â
Warts may appear within weeks or months of acquiring the infection. The acuity may also depend on the location and size of the warts. Warts in more visible or sensitive areas may prompt individuals to seek medical attention sooner.Â
The individual’s immune response plays a significant role in the acuity of genital warts. Those with a robust immune response may clear the infection more effectively or experience a milder presentation.Â
Â
Â
Â
Â
Podofilox: It is a topical antimitotic agent that interferes with cell division, leading to the death of HPV-infected cells.Â
Interferon: Interferon is a protein with antiviral properties that may be injected directly into the warts (intralesional injection) to stimulate the immune system’s response.Â
Â
Condylomata acuminata, commonly known as genital warts, is a sexually transmitted infection (STI) caused by certain strains of the human papillomavirus (HPV). HPV is a group of viruses that can infect the genital and anal areas, as well as the mouth and throat. Â
The primary cause of genital warts is infection with HPV, particularly strains 6 and 11. These strains are considered low-risk and are not associated with an increased risk of cancer.Â
Genital warts often appear as small, flesh-colored bumps or growths in the genital or anal area. They can be raised or flat and may occur singly or in clusters. Â
Â
HPV is one of the most common sexually transmitted infections globally. The prevalence of HPV infection varies across populations, with higher rates seen in sexually active individuals.Â
Both men and women can develop genital warts, and the prevalence is generally similar in both genders. Genital warts are primarily transmitted through sexual contact, including vaginal, anal, and oral sex.Â
Risk factors for acquiring genital warts include having multiple sexual partners, engaging in unprotected sex, and a history of other sexually transmitted infections.Â
Â
Genital warts are primarily transmitted through direct skin-to-skin contact during sexual activity. HPV enters the body through microabrasions or breaks in the skin or mucous membranes of the genital, anal, or oral areas.Â
The virus enters the host cell and establishes a productive infection, leading to the replication of viral DNA. The virus completes its life cycle in the differentiated layers of the epithelium, leading to the production of viral particles.Â
HPV has evolved mechanisms to evade the immune system, allowing it to establish persistent infections. The virus can interfere with host immune responses, making it challenging for the body to clear the infection.Â
Â
Genital warts are primarily caused by infection with HPV, a group of DNA viruses. HPV is highly prevalent, and there are over 100 known types, with some affecting the genital and anal areas.Â
These types are considered low risk because they are not associated with an increased risk of cancer, unlike high-risk HPV types that are linked to cancers such as cervical cancer.Â
HPV is primarily transmitted through direct skin-to-skin contact, usually during sexual activity. Transmission can occur through vaginal, anal, or oral sex, and the virus can be passed even when there are no visible warts.Â
The virus infects basal epithelial cells, which are found in the outer layer of the skin and mucous membranes.Â
Â
The immune system plays a crucial role in controlling and clearing HPV infections, including those causing genital warts.Â
Individuals with compromised immune systems, such as those with HIV or on immunosuppressive medications, may experience more persistent or recurrent infections.Â
Â
Age Group:Â Â
Genital warts are frequently diagnosed in individuals who are sexually active during their late teens and early twenties.Â
Genital warts are primarily transmitted through sexual contact, including vaginal, anal, and oral sex.Â
Individuals become more sexually active during their late teens and early twenties, leading to an increased risk of exposure to HPV.Â
Â
Â
In pregnant women, genital warts can pose certain risks, especially if the warts are present in the genital or perianal area.Â
In rare cases, the presence of large warts may necessitate interventions during childbirth to prevent obstruction of the birth canal.Â
While Condylomata acuminata itself is not directly linked to HIV transmission, the presence of genital warts may increase the risk of HIV acquisition or transmission in individuals who are also at risk for HIV.Â
Â
For individuals who do develop visible warts, the onset can be relatively rapid after exposure to the human papillomavirus (HPV).Â
Warts may appear within weeks or months of acquiring the infection. The acuity may also depend on the location and size of the warts. Warts in more visible or sensitive areas may prompt individuals to seek medical attention sooner.Â
The individual’s immune response plays a significant role in the acuity of genital warts. Those with a robust immune response may clear the infection more effectively or experience a milder presentation.Â
Â
Â
Â
Â
Podofilox: It is a topical antimitotic agent that interferes with cell division, leading to the death of HPV-infected cells.Â
Interferon: Interferon is a protein with antiviral properties that may be injected directly into the warts (intralesional injection) to stimulate the immune system’s response.Â
Â

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
